Option Care Health, Inc. OPCH Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001014739-25-000022
cik 1014739
name OPTION CARE HEALTH, INC.
sic 8082
countryba US
stprba IL
cityba BANNOCKBURN
zipba 60015
bas1 3000 LAKESIDE DR
bas2 SUITE 300N
baph 312 940 2443
countryma US
stprma IL
cityma BANNOCKBURN
zipma 60015
mas1 3000 LAKESIDE DR
mas2 SUITE 300N
countryinc US
stprinc DE
ein 050489664
former BIOSCRIP, INC.
changed 20050314
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250429
accepted 2025-04-29 16:01:00.0
prevrpt 0
detail 1
instance bios-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001014739-25-000022 20250331 Accounts Payable Current 528848000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Additional Paid In Capital Common Stock 1231435000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 8801000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Assets Current 1322627000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Common Stock Shares Outstanding 173816000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20240331 Earnings Per Share Diluted 0.2600 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Employee Related Liabilities Current 63028000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Equity Method Investment Dividends Or Distributions 800000.0000 USD 1 us-gaap/2024 Related Party Transactions By Related Party= Corporate Joint Venture;
0001014739-25-000022 20250331 Income Taxes Paid Net 833000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Interest Expense Nonoperating 13202000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Liabilities 2017505000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Liabilities And Stockholders Equity 3421743000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Net Cash Provided By Used In Financing Activities -49732000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Net Cash Provided By Used In Operating Activities -7214000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Operating Expenses 169470000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Other Nonoperating Income Expense 2000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Other Nonoperating Income Expense -4130000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20240331 Payments For Repurchase Of Common Stock And Related Excise Taxes 40050000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20240331 Payments To Acquire Property Plant And Equipment 5820000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Payments To Acquire Property Plant And Equipment 9371000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001014739-25-000022 20240331 Repayments Of Debt 1500000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Retained Earnings Accumulated Deficit 669336000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Revenues 1146052000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20240331 Revenues 988043000.0000 USD 1 us-gaap/2024 Major Customers= Commercial Customer;
0001014739-25-000022 20240331 Revenues 138310000.0000 USD 1 us-gaap/2024 Major Customers= Government Customer;
0001014739-25-000022 20250331 Revenues 27522000.0000 USD 1 us-gaap/2024 Major Customers= Patient Customer;
0001014739-25-000022 20240331 Stockholders Equity 1429148000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Stockholders Equity 1231435000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20250331 Treasury Stock Common Shares 20631828.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Weighted Average Number Of Shares Outstanding Basic 165460000.0000 shares 1 us-gaap/2024
0001014739-25-000022 20241231 Accrued Expenses And Other Current Liabilities 77783000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20250331 Assets Current 1099375000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Assets Noncurrent 2209138000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 171372000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001014739-25-000022 20231231 Common Stock Shares Outstanding 174576000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20241231 Common Stock Shares Outstanding 166261112.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Depreciation Amortization And Accretion Net 16373000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Depreciation Depletion And Amortization 15746000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Finite Lived Intangible Assets Net Excluding Customer Lists 16993000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20250331 Finite Lived Intangible Assets Net Excluding Customer Lists 24427000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20250331 Income Loss From Equity Method Investments 1729000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20240331 Income Tax Expense Benefit 12164000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Increase Decrease In Accounts Payable Trade -88101000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Other Noncurrent Assets And Liabilities Net 418000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -4878000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Receivables 195992000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Interest Expense Nonoperating 13202000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Net Cash Provided By Used In Investing Activities -126693000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Net Income Loss 44791000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20250331 Net Income Loss 46742000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20250331 Nonoperating Income Expense -15632000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Operating Expenses 183864000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Operating Lease Right Of Use Asset Amortization Expense 9002000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent 454000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Payments Related To Tax Withholding For Share Based Compensation 8182000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Payments Related To Tax Withholding For Share Based Compensation 7385000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Payments To Acquire Businesses Net Of Cash Acquired 117322000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001014739-25-000022 20240331 Proceeds From Payments For Other Financing Activities 0.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Revenues 19699000.0000 USD 1 us-gaap/2024 Major Customers= Patient Customer;
0001014739-25-000022 20250331 Revenues 160518000.0000 USD 1 us-gaap/2024 Major Customers= Government Customer;
0001014739-25-000022 20240331 Share Based Compensation 9605000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20231231 Stockholders Equity 1421672000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Treasury Stock Common Shares 17585613.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Accounts Receivable Net Current 476649000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 8801000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20250331 Cash And Cash Equivalents At Carrying Value 171372000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 219513000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Depreciation Depletion And Amortization 15746000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Earnings Per Share Basic 0.2800 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Interest Expense Nonoperating 13231000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20240331 Net Cash Provided By Used In Operating Activities -68784000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Operating Lease Payments Use 7085000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Other Assets Noncurrent 43965000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent 1551000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent -783000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 1551000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20250331 Other Liabilities Noncurrent 1084000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Other Operating Activities Cash Flow Statement -949000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Payments To Acquire Businesses Net Of Cash Acquired 0.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250131 Payments To Acquire Businesses Net Of Cash Acquired 117322000.0000 USD 0 us-gaap/2024 Business Acquisition= Intramed Plus Inc;
0001014739-25-000022 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Proceeds From Payments For Other Financing Activities 1949000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Stockholders Equity 16529000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20241231 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20250331 Stockholders Equity 1350834000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Weighted Average Number Of Shares Outstanding Basic 173928000.0000 shares 1 us-gaap/2024
0001014739-25-000022 20250331 Interest Paid Net 10763000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 8649000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 343849000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001014739-25-000022 20241231 Common Stock Value 18000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Deferred Income Tax Expense Benefit 1370000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Earnings Per Share Diluted 0.2800 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Finite Lived Customer Lists Net 284017000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20250331 Finite Lived Customer Lists Net 312586000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20241231 Goodwill 1540246000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Goodwill 1605930000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 63556000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Income Tax Expense Benefit 12164000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Employee Related Liabilities -49884000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -28444000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Long Term Debt Current 6512000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Long Term Debt Noncurrent 1104160000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Net Income Loss 44791000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Net Income Loss 44791000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Operating Lease Payments Use 7548000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 1551000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Other Operating Activities Cash Flow Statement 108000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Prepaid Expense And Other Assets Current 112198000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Property Plant And Equipment Net 131264000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Retained Earnings Accumulated Deficit 716078000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Revenues 1144932000.0000 USD 1 us-gaap/2024 Major Customers= Commercial Customer;
0001014739-25-000022 20240331 Stock Repurchased During Period Value Including Related Tax Effects 40289000.0000 USD 1 0001014739-25-000022 Equity Components= Treasury Stock Common;
0001014739-25-000022 20250331 Stock Repurchased During Period Value Including Related Tax Effects 101113000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20241231 Accounts Payable Current 610779000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Accounts Receivable Net Current 409733000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Accrued Expenses And Other Current Liabilities 106177000.0000 USD 0 0001014739-25-000022
0001014739-25-000022 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9605000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20241231 Assets 3421743000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 412565000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Common Stock Shares Issued 183846725.0000 shares 0 us-gaap/2024
0001014739-25-000022 20240331 Comprehensive Income Net Of Tax 46342000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Cost Of Goods And Services Sold 1069920000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Employee Related Liabilities Current 49664000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Gross Profit 238500000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 56955000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Income Tax Expense Benefit 16814000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Accounts Payable Trade 59223000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Inventories -32056000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Increase Decrease In Inventories -21790000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 6811000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Interest Paid Net 12173000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Liabilities Noncurrent 1244015000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Net Cash Provided By Used In Investing Activities -5820000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Operating Lease Liability Current 22044000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Operating Lease Right Of Use Asset Amortization Expense 7663000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Assets Noncurrent 43981000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Selling General And Administrative Expense 154742000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20231231 Stockholders Equity 14978000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20231231 Stockholders Equity 1204270000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20231231 Stockholders Equity -255107000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001014739-25-000022 20240331 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20241231 Stockholders Equity 11047000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001014739-25-000022 20250331 Stockholders Equity -608711000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001014739-25-000022 20240331 Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 8182000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20240331 Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 8182000.0000 USD 1 0001014739-25-000022 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20240331 Stock Repurchased During Period Value Including Related Tax Effects 40289000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20241231 Treasury Stock Common Value 507598000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Preferred Stock Shares Authorized 12500000.0000 shares 0 us-gaap/2024
0001014739-25-000022 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 11047000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Amortization Of Financing Costs And Discounts 1132000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Assets 3308513000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Cash And Cash Equivalents At Carrying Value 412565000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -241193000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Shares Outstanding 163744000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20240331 Cost Of Goods And Services Sold 907552000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Depreciation Depletion And Amortization 14728000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20240331 Equity Method Investment Dividends Or Distributions 750000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Equity Method Investment Dividends Or Distributions 0.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Income Loss From Equity Method Investments 1125000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Income Taxes Paid Net 2000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Increase Decrease In Employee Related Liabilities -14458000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Inventory Net 388131000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Inventory Net 369034000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Liabilities 1957679000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Liabilities Current 713664000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Net Income Loss 46742000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Net Income Loss 46742000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Operating Lease Liability Current 22463000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Operating Lease Liability Noncurrent 89825000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Operating Lease Payments 6651000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent -2398000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent -2398000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20240331 Other Nonoperating Income Expense 2000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Nonoperating Income Expense -4130000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Payments For Repurchase Of Common Stock And Related Excise Taxes 100222000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20250331 Prepaid Expense And Other Assets Current 82320000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Revenues 1146052000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Revenues 1332972000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Revenues 1332972000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Share Based Compensation 8801000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20231231 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20231231 Stockholders Equity 457513000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20240331 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001014739-25-000022 20240331 Stockholders Equity -295396000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001014739-25-000022 20241231 Stockholders Equity -507598000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001014739-25-000022 20250331 Stockholders Equity 18000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20250331 Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 5436000.0000 USD 1 0001014739-25-000022
0001014739-25-000022 20250331 Treasury Stock Common Value 608711000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Weighted Average Number Of Diluted Shares Outstanding 175624000.0000 shares 1 us-gaap/2024
0001014739-25-000022 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9605000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Amortization Of Financing Costs And Discounts 1147000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Common Stock Shares Outstanding 166261000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001014739-25-000022 20241231 Deferred Income Tax Liabilities Net 47576000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Deferred Income Tax Liabilities Net 48946000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Depreciation Depletion And Amortization 14728000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Gross Profit 263052000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Income Tax Expense Benefit 16814000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Increase Decrease In Other Accounts Payable And Accrued Liabilities 27503000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Increase Decrease In Receivables 56788000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Interest Expense Nonoperating 13231000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Investment Income Net 1125000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Liabilities And Stockholders Equity 3308513000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Liabilities Current 780146000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Liabilities Noncurrent 1237359000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Long Term Debt Current 6512000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Nonoperating Income Expense -12075000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Operating Income Loss 69030000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Operating Lease Liability Noncurrent 84776000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Operating Lease Right Of Use Asset 86528000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Operating Lease Right Of Use Asset 90950000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Property Plant And Equipment Net 127367000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Repayments Of Debt 1628000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20231231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001014739-25-000022 20240331 Stockholders Equity 1205693000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20240331 Stockholders Equity 502304000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20241231 Stockholders Equity 0.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock;
0001014739-25-000022 20241231 Stockholders Equity 669336000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20250331 Stockholders Equity 8649000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001014739-25-000022 20250331 Stockholders Equity 716078000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001014739-25-000022 20250331 Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 5436000.0000 USD 1 0001014739-25-000022 Equity Components= Additional Paid In Capital;
0001014739-25-000022 20250331 Stock Repurchased During Period Value Including Related Tax Effects 101113000.0000 USD 1 0001014739-25-000022 Equity Components= Treasury Stock Common;
0001014739-25-000022 20250331 Weighted Average Number Of Diluted Shares Outstanding 166804000.0000 shares 1 us-gaap/2024
0001014739-25-000022 20250331 Additional Paid In Capital Common Stock 1234800000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Assets Noncurrent 2099116000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -124336000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Shares Issued 184376321.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Shares Outstanding 163744493.0000 shares 0 us-gaap/2024
0001014739-25-000022 20250331 Common Stock Value 18000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Comprehensive Income Net Of Tax 44344000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Deferred Income Tax Expense Benefit 2964000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Depreciation Amortization And Accretion Net 15305000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20240331 Earnings Per Share Basic 0.2600 USD 1 us-gaap/2024
0001014739-25-000022 20250131 Goodwill 65684000.0000 USD 0 us-gaap/2024 Business Acquisition= Intramed Plus Inc;
0001014739-25-000022 20240331 Income Loss From Equity Method Investments 1125000.0000 USD 1 us-gaap/2024 Business Segments= Reportable Segment;
0001014739-25-000022 20250331 Income Loss From Equity Method Investments 1729000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Increase Decrease In Other Noncurrent Assets And Liabilities Net -1595000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Investment Income Net 1729000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Long Term Debt Noncurrent 1104641000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Net Cash Provided By Used In Financing Activities -107286000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Operating Income Loss 79188000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Operating Lease Payments 7956000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent -2398000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Other Liabilities Noncurrent 366000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Selling General And Administrative Expense 168118000.0000 USD 1 us-gaap/2024
0001014739-25-000022 20241231 Stockholders Equity 1404238000.0000 USD 0 us-gaap/2024
0001014739-25-000022 20250331 Stockholders Equity 1234800000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Increase Decrease In Accounts Payable Trade us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable, Trade Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.
Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 0 0 monetary D C Payments to Acquire Businesses, Net of Cash Acquired The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Receivables us-gaap/2024 0 0 monetary D C Increase (Decrease) in Receivables The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.
Other Operating Activities Cash Flow Statement us-gaap/2024 0 0 monetary D D Other Operating Activities, Cash Flow Statement Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Depreciation Amortization And Accretion Net us-gaap/2024 0 0 monetary D D Depreciation, Amortization and Accretion, Net The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Operating Lease Payments Use us-gaap/2024 0 0 monetary D C Operating Lease, Payments, Use Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Operating Lease Payments us-gaap/2024 0 0 monetary D C Operating Lease, Payments Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Amortization Of Financing Costs And Discounts us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs and Discounts Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Employee Related Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Employee Related Liabilities Current us-gaap/2024 0 0 monetary I C Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Increase Decrease In Other Noncurrent Assets And Liabilities Net us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.
Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Proceeds From Payments For Other Financing Activities us-gaap/2024 0 0 monetary D D Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other.
Repayments Of Debt us-gaap/2024 0 0 monetary D C Repayments of Debt Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.
Accrued Expenses And Other Current Liabilities 0001014739-25-000022 1 0 monetary I C Accrued Expenses And Other Current Liabilities Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Used to reflect the current portion of the liabilities, combined with the aggregate carrying amount, as of the balance sheet date, of current obligations not separately disclosed in the balance sheet due to materiality considerations.
Finite Lived Intangible Assets Net Excluding Customer Lists 0001014739-25-000022 1 0 monetary I D Finite-Lived Intangible Assets, Net, Excluding Customer Lists Finite-Lived Intangible Assets, Net, Excluding Customer Lists
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Equity Method Investment Dividends Or Distributions us-gaap/2024 0 0 monetary D D Proceeds from Equity Method Investment, Distribution Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Amount after tax of other comprehensive income (loss) attributable to parent entity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Finite Lived Customer Lists Net 0001014739-25-000022 1 0 monetary I D Finite Lived Customer Lists, Net Finite Lived Customer Lists, Net
Stock Repurchased During Period Value Including Related Tax Effects 0001014739-25-000022 1 0 monetary D D Stock Repurchased During Period, Value, Including Related Tax Effects Stock Repurchased During Period, Value, Including Related Tax Effects
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Assets Noncurrent us-gaap/2024 0 0 monetary I D Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Investment Income Net us-gaap/2024 0 0 monetary D C Investment Income, Net Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent us-gaap/2024 0 0 monetary D D Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Treasury Stock Common Value us-gaap/2024 0 0 monetary I D Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
Payments For Repurchase Of Common Stock And Related Excise Taxes 0001014739-25-000022 1 0 monetary D C Payments for Repurchase of Common Stock and Related Excise Taxes Payments for Repurchase of Common Stock and Related Excise Taxes
Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 0001014739-25-000022 1 0 monetary D D Stock Issued, Value, Restricted Stock, Stock Options Exercised and Tax Withholdings Stock Issued, Value, Restricted Stock, Stock Options Exercised and Tax Withholdings
Long Term Debt Current us-gaap/2024 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001014739-25-000022 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001014739-25-000022 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0001014739-25-000022 2 5 BS 0 H Inventory Net us-gaap/2024 Inventories 0
0001014739-25-000022 2 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001014739-25-000022 2 7 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001014739-25-000022 2 9 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001014739-25-000022 2 10 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use asset 0
0001014739-25-000022 2 11 BS 0 H Finite Lived Intangible Assets Net Excluding Customer Lists 0001014739-25-000022 Intangible assets, net 0
0001014739-25-000022 2 12 BS 0 H Finite Lived Customer Lists Net 0001014739-25-000022 Referral sources, net 0
0001014739-25-000022 2 13 BS 0 H Goodwill us-gaap/2024 Goodwill (2) 0
0001014739-25-000022 2 14 BS 0 H Other Assets Noncurrent us-gaap/2024 Other noncurrent assets 0
0001014739-25-000022 2 15 BS 0 H Assets Noncurrent us-gaap/2024 Total noncurrent assets 0
0001014739-25-000022 2 16 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001014739-25-000022 2 19 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001014739-25-000022 2 20 BS 0 H Employee Related Liabilities Current us-gaap/2024 Accrued compensation and employee benefits 0
0001014739-25-000022 2 21 BS 0 H Accrued Expenses And Other Current Liabilities 0001014739-25-000022 Accrued expenses and other current liabilities 0
0001014739-25-000022 2 22 BS 0 H Operating Lease Liability Current us-gaap/2024 Current portion of operating lease liability 0
0001014739-25-000022 2 23 BS 0 H Long Term Debt Current us-gaap/2024 Current portion of long-term debt 0
0001014739-25-000022 2 24 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001014739-25-000022 2 26 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt, net of discount, deferred financing costs and current portion 0
0001014739-25-000022 2 27 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liability, net of current portion 0
0001014739-25-000022 2 28 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred income taxes 0
0001014739-25-000022 2 29 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other noncurrent liabilities 0
0001014739-25-000022 2 30 BS 0 H Liabilities Noncurrent us-gaap/2024 Total noncurrent liabilities 0
0001014739-25-000022 2 31 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001014739-25-000022 2 33 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of March 31, 2025 and December 31, 2024 0
0001014739-25-000022 2 34 BS 0 H Common Stock Value us-gaap/2024 Common stock; $0.0001 par value: 250,000,000 shares authorized, 184,376,321 shares issued and 163,744,493 shares outstanding as of March 31, 2025; 183,846,725 shares issued and 166,261,112 shares outstanding as of December 31, 2024 0
0001014739-25-000022 2 35 BS 0 H Treasury Stock Common Value us-gaap/2024 Treasury stock; 20,631,828 and 17,585,613 shares outstanding, at cost, as of March 31, 2025 and December 31, 2024, respectively 1
0001014739-25-000022 2 36 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Paid-in capital 0
0001014739-25-000022 2 37 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001014739-25-000022 2 38 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0001014739-25-000022 2 39 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001014739-25-000022 2 40 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY 0
0001014739-25-000022 3 1 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0001014739-25-000022 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized (in shares) 0
0001014739-25-000022 3 3 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares, outstanding (in shares) 0
0001014739-25-000022 3 4 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001014739-25-000022 3 5 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001014739-25-000022 3 6 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares, issued (in shares) 0
0001014739-25-000022 3 7 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares, outstanding (in shares) 0
0001014739-25-000022 3 8 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock, at cost (in shares) 0
0001014739-25-000022 4 1 IS 0 H Revenues us-gaap/2024 NET REVENUE 0
0001014739-25-000022 4 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 COST OF REVENUE 0
0001014739-25-000022 4 3 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0001014739-25-000022 4 5 IS 0 H Selling General And Administrative Expense us-gaap/2024 Selling, general and administrative expenses 0
0001014739-25-000022 4 6 IS 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization expense 0
0001014739-25-000022 4 7 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001014739-25-000022 4 8 IS 0 H Operating Income Loss us-gaap/2024 OPERATING INCOME 0
0001014739-25-000022 4 10 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense, net 1
0001014739-25-000022 4 11 IS 0 H Investment Income Net us-gaap/2024 Equity in earnings of joint ventures 0
0001014739-25-000022 4 12 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other, net 0
0001014739-25-000022 4 13 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other expense 0
0001014739-25-000022 4 14 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 INCOME BEFORE INCOME TAXES 0
0001014739-25-000022 4 15 IS 0 H Income Tax Expense Benefit us-gaap/2024 INCOME TAX EXPENSE 0
0001014739-25-000022 4 16 IS 0 H Net Income Loss us-gaap/2024 NET INCOME 0
0001014739-25-000022 4 18 IS 0 H Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent us-gaap/2024 Change in unrealized (loss) gain on cash flow hedges, net of income tax benefit (expense) of $783 and $(454), respectively 0
0001014739-25-000022 4 19 IS 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 OTHER COMPREHENSIVE (LOSS) INCOME 0
0001014739-25-000022 4 20 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 NET COMPREHENSIVE INCOME 0
0001014739-25-000022 4 22 IS 0 H Earnings Per Share Basic us-gaap/2024 Earnings per share, basic (in dollars per share) 0
0001014739-25-000022 4 23 IS 0 H Earnings Per Share Diluted us-gaap/2024 Earnings per share, diluted (in dollars per share) 0
0001014739-25-000022 4 24 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding, basic (in shares) 0
0001014739-25-000022 4 25 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average common shares outstanding, diluted (in shares) 0
0001014739-25-000022 5 1 IS 1 H Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent us-gaap/2024 Change in unrealized (loss) gain on cash flows, income tax benefit (expense) 1
0001014739-25-000022 6 2 CF 0 H Net Income Loss us-gaap/2024 Net income 0
0001014739-25-000022 6 4 CF 0 H Depreciation Amortization And Accretion Net us-gaap/2024 Depreciation and amortization expense 0
0001014739-25-000022 6 5 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Non-cash operating lease costs 0
0001014739-25-000022 6 6 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Deferred income taxes - net 0
0001014739-25-000022 6 7 CF 0 H Amortization Of Financing Costs And Discounts us-gaap/2024 Amortization of deferred financing costs 0
0001014739-25-000022 6 8 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Equity in earnings of joint ventures 1
0001014739-25-000022 6 9 CF 0 H Share Based Compensation us-gaap/2024 Stock-based incentive compensation expense 0
0001014739-25-000022 6 10 CF 0 H Equity Method Investment Dividends Or Distributions us-gaap/2024 Distribution from equity method investments 0
0001014739-25-000022 6 11 CF 0 H Other Operating Activities Cash Flow Statement us-gaap/2024 Other adjustments 0
0001014739-25-000022 6 13 CF 0 H Increase Decrease In Receivables us-gaap/2024 Accounts receivable, net 1
0001014739-25-000022 6 14 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0001014739-25-000022 6 15 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001014739-25-000022 6 16 CF 0 H Increase Decrease In Accounts Payable Trade us-gaap/2024 Accounts payable 0
0001014739-25-000022 6 17 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2024 Accrued compensation and employee benefits 0
0001014739-25-000022 6 18 CF 0 H Increase Decrease In Other Accounts Payable And Accrued Liabilities us-gaap/2024 Accrued expenses and other current liabilities 0
0001014739-25-000022 6 19 CF 0 H Operating Lease Payments us-gaap/2024 Operating lease liabilities 1
0001014739-25-000022 6 20 CF 0 H Increase Decrease In Other Noncurrent Assets And Liabilities Net us-gaap/2024 Other noncurrent assets and liabilities 1
0001014739-25-000022 6 21 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001014739-25-000022 6 23 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Acquisition of property and equipment 1
0001014739-25-000022 6 24 CF 0 H Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 Business acquisitions, net of cash acquired 1
0001014739-25-000022 6 25 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001014739-25-000022 6 27 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Stock-based compensation tax withholdings 1
0001014739-25-000022 6 28 CF 0 H Payments For Repurchase Of Common Stock And Related Excise Taxes 0001014739-25-000022 Purchase of company stock, and related excise taxes 1
0001014739-25-000022 6 29 CF 0 H Repayments Of Debt us-gaap/2024 Repayments of debt principal 1
0001014739-25-000022 6 30 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2024 Other financing activities 0
0001014739-25-000022 6 31 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash used in financing activities 0
0001014739-25-000022 6 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET DECREASE IN CASH AND CASH EQUIVALENTS 0
0001014739-25-000022 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents - beginning of the period 0
0001014739-25-000022 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 CASH AND CASH EQUIVALENTS - END OF PERIOD 0
0001014739-25-000022 6 36 CF 0 H Interest Paid Net us-gaap/2024 Cash paid for interest 0
0001014739-25-000022 6 37 CF 0 H Income Taxes Paid Net us-gaap/2024 Cash paid for income taxes 0
0001014739-25-000022 6 38 CF 0 H Operating Lease Payments Use us-gaap/2024 Cash paid for operating leases 0
0001014739-25-000022 7 12 EQ 0 H Stockholders Equity us-gaap/2024 Equity, beginning balance 0
0001014739-25-000022 7 13 EQ 0 H Stock Issued Value Restricted Stock Stock Options Exercised And Tax Withholdings 0001014739-25-000022 Exercise of stock options, vesting of restricted stock, and related tax withholdings 1
0001014739-25-000022 7 14 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based incentive compensation 0
0001014739-25-000022 7 15 EQ 0 H Stock Repurchased During Period Value Including Related Tax Effects 0001014739-25-000022 Purchase of company stock, and related tax effects 1
0001014739-25-000022 7 16 EQ 0 H Net Income Loss us-gaap/2024 Net income 0
0001014739-25-000022 7 17 EQ 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent us-gaap/2024 Other comprehensive income (loss) 0
0001014739-25-000022 7 18 EQ 0 H Stockholders Equity us-gaap/2024 Equity, ending balance 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.